As expected, DDX39B P322A mutant (blockage of DDX39B-TRIM28 complex formation) or 3KR mutant (interruption of TRIM28-induced DDX39B ubiquitination) restricted the pro-metastatic potential of DDX39B in NSCLC cells. The gene discussed is DDX39B; the disease is non-small cell lung carcinoma.